These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1473526)

  • 61. Interstitial lung disease in systemic sclerosis: comparison of BALF lymphocyte phenotype and DLCO impairment.
    Domagała-Kulawik J; Hoser G; Doboszyńska A; Kawiak J; Droszcz W
    Respir Med; 1998 Nov; 92(11):1295-301. PubMed ID: 9926143
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Human epidermal cells from ultraviolet light-exposed skin preferentially activate autoreactive CD4+2H4+ suppressor-inducer lymphocytes and CD8+ suppressor/cytotoxic lymphocytes.
    Baadsgaard O; Fox DA; Cooper KD
    J Immunol; 1988 Mar; 140(6):1738-44. PubMed ID: 2964481
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Induction of ovarian tumor-specific CD8+ cytotoxic T lymphocytes by acid-eluted peptide-pulsed autologous dendritic cells.
    Santin AD; Bellone S; Ravaggi A; Pecorelli S; Cannon MJ; Parham GP
    Obstet Gynecol; 2000 Sep; 96(3):422-30. PubMed ID: 10960637
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Regulatory B cells contribute to the impaired antitumor immunity in ovarian cancer patients.
    Wei X; Jin Y; Tian Y; Zhang H; Wu J; Lu W; Lu X
    Tumour Biol; 2016 May; 37(5):6581-8. PubMed ID: 26638169
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Depression of thymus-dependent immunity in wasting protein-energy malnutrition does not depend on an altered ratio of helper (CD4+) to suppressor (CD8+) T cells or on a disproportionately large atrophy of the T-cell relative to the B-cell pool.
    Woodward BD; Miller RG
    Am J Clin Nutr; 1991 May; 53(5):1329-35. PubMed ID: 1673590
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Lymphokine-activated killer activity of tumor-associated and peripheral blood lymphocytes isolated from patients with ascites ovarian tumors.
    Allavena P; Zanaboni F; Rossini S; Merendino A; Bonazzi C; Vassena L; Mangioni C; Mantovani A
    J Natl Cancer Inst; 1986 Oct; 77(4):863-8. PubMed ID: 3489856
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prospective comparison of blood and peritoneal lymphocytes from continuous ambulatory peritoneal dialysis patients.
    Lewis SL; Bonner PN; Cooper CL; Holmes CJ
    J Clin Lab Immunol; 1992 Jan; 37(1):3-19. PubMed ID: 1339234
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effects of cardiopulmonary bypass on lymphocytes and their subset counts with or without use of autotransfusion devices.
    Perttilä J; Salo M; Pirttikangas CO; Jalonen J; Vainio O
    J Cardiothorac Vasc Anesth; 1994 Oct; 8(5):532-5. PubMed ID: 7803741
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Differential expression of cytokine transcripts in human epithelial ovarian carcinoma by solid tumour specimens, peritoneal exudate cells containing tumour, tumour-infiltrating lymphocyte (TIL)-derived T cell lines and established tumour cell lines.
    Nash MA; Lenzi R; Edwards CL; Kavanagh JJ; Kudelka AP; Verschraegen CF; Platsoucas CD; Freedman RS
    Clin Exp Immunol; 1998 May; 112(2):172-80. PubMed ID: 9649178
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Tumor lymphocytes in patients with advanced ovarian cancer: changes during in vitro culture and implications for immunotherapy.
    Han X; Papadopoulos AJ; Ruparelia V; Devaja O; Raju KS
    Gynecol Oncol; 1997 Jun; 65(3):391-8. PubMed ID: 9190963
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Immune modulation during treatment of systemic sclerosis with plasmapheresis and immunosuppressive drugs.
    Dau PC; Callahan JP
    Clin Immunol Immunopathol; 1994 Feb; 70(2):159-65. PubMed ID: 8299231
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Interleukin 1 beta synergises with interleukin 2 in the outgrowth of autologous tumour-reactive CD8+ effectors.
    Baxevanis CN; Dedoussis GV; Gritzapis AD; Stathopoulos GP; Papamichail M
    Br J Cancer; 1994 Oct; 70(4):625-30. PubMed ID: 7917907
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Increase in activated CD8+ cells in bronchoalveolar lavage fluid in patients with diffuse panbronchiolitis.
    Mukae H; Kadota J; Kohno S; Kusano S; Morikawa T; Matsukura S; Hara K
    Am J Respir Crit Care Med; 1995 Aug; 152(2):613-8. PubMed ID: 7633715
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Subpopulations of CD4 and CD8 lymphocytes in peripheral blood of patients with non-toxic thyroid nodular goitre].
    Mielczarek-Palacz A; Kondera-Anasz Z; Mertas A; Rudowska E; Bobrowska-Raczka J
    Wiad Lek; 2003; 56(1-2):24-7. PubMed ID: 12901264
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Patient inflammatory status and CD4+/CD8+ intraepithelial tumor lymphocyte infiltration are predictors of outcomes in high-grade serous ovarian cancer.
    Pinto MP; Balmaceda C; Bravo ML; Kato S; Villarroel A; Owen GI; Roa JC; Cuello MA; Ibañez C
    Gynecol Oncol; 2018 Oct; 151(1):10-17. PubMed ID: 30078505
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Analysis of peritoneal leukocyte population with different dialysis fluids.
    Palomar R; López-Hoyos M; Morales P; Marín MJ; Alvarez L; Ruiz-Soto M; Rodrigo E; Fernández-Fresnedo G; Lm de Francisco A; Arias M
    Clin Nephrol; 2009 Aug; 72(2):137-42. PubMed ID: 19640371
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Gains and losses of CD8, CD20 and CD56 expression in tumor stroma-infiltrating lymphocytes compared with tumor-associated lymphocytes from ascitic fluid and lymphocytes from tumor draining lymph nodes in serous papillary ovarian carcinoma patients.
    Papadopoulos N; Kotini A; Cheva A; Jivannakis T; Manavis J; Alexiadis G; Lambropoulou M; Vavetsis S; Tamiolakis D
    Eur J Gynaecol Oncol; 2002; 23(6):533-6. PubMed ID: 12556098
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features.
    D'Arena G; Musto P; Cascavilla N; Di Giorgio G; Fusilli S; Zendoli F; Carotenuto M
    Haematologica; 1998 Mar; 83(3):197-203. PubMed ID: 9573672
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The number of tumor infiltrating T-cell subsets in lymph nodes from patients with Hodgkin lymphoma is associated with the outcome after first line ABVD therapy.
    Alonso-Álvarez S; Vidriales MB; Caballero MD; Blanco O; Puig N; Martin A; Peñarrubia MJ; Zato E; Galende J; Bárez A; Alcoceba M; Orfão A; González M; García-Sanz R
    Leuk Lymphoma; 2017 May; 58(5):1144-1152. PubMed ID: 27733075
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Peripheral lymphocyte subpopulations in recurrent aphthous ulceration.
    Pedersen A; Klausen B; Hougen HP; Ryder LP
    Acta Odontol Scand; 1991 Aug; 49(4):203-6. PubMed ID: 1681668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.